Xerthra MONOSHOT

PRP behandling
PACKSOT_MONOSHOT

MONOSHOT provides simultaneous effect of HYALURONIC ACID and PLATELET-RICH PLASMA with

LEUKOCYTES:

  • platelets release growth factors, which stimulate regeneration of damaged joint tissues.
  • leukocytes injected into the inflamed area serve regulatory and organizing role
  • Biolevox™ HA hyaluronic acid restores proper viscoelastic properties of synovial fluid and brings anti-catabolic effect in the joint.

INDICATIONS: INJURIES AND ADVANCED STAGE OF OA DUE TO COMBINED AND STRONGER EFFECT OF THE

INGREDIENTS

advanced stage of OA with increased inflammation,

  • PRP+HA brings the combined and stronger action of its ingredients
  • Effectiveness of platelet rich plasma therapy depends on platelets amount contained in autologous plasma, because it has a direct impact on the growth factors amount in the product. Only concentration of platelet >1 million PLT/μl ensures the effectiveness of the therapy.
    The highest concentration of platelets can only be obtained with specially dedicated devices. XerthraTM separa- tion device allows on average 1.5 million PLT/μl to be obtained, what gives 8 times higher concentration than in the peripheral blood.